watchLAB is conducting a market research study by phone with Atrial Fibrillation patients throughout the US who have had both chemical (IV) and electrical cardioversions, preferably in the past 2 years. See below for the definitions they have supplied to help you determine if you are qualified to participate. If you qualify, you will be …
Read MoreArchives
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial …
Read MoreSince I posted a few days ago on Statins Help Women with Atrial Fibrillation, Hans Larsen, owner of the Lone Atrial Fibrillation Bulletin Board, created a great recap of studies related to inflammation and atrial fibrillation, including lone atrial fibrillation (afib without any underlying heart disease). It's definitely worth checking out to find out more about inflammation. Some findings he included …
Read More